Brief: Clearpoint Neuro Reports Q4 2020 Results
March 4 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* Q4 REVENUE ROSE 16% TO $3.7 MILLION
* QTRLY NET LOSS PER SHARE BASIC AND DILUTED $0.09
Source text for Eikon: ID:nGNX9jzyqS
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearpoint Neuro
See all newsClearpoint Neuro Inc reports results for the quarter ended June 30 - Earnings Summary
ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Brief: ClearPoint Neuro Q2 Revenue USD 10.9 Million
ClearPoint Neuro Q1 revenue rises 43%, beats estimates
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition